EUVIMEDEUVIMED entdecken
Crossref

Berberine ameliorates glucocorticoid-induced hyperglycemia: an in vitro and in vivo study

Mrinal Gupta, Mohammad Rumman, Babita Singh, Abbas Ali Mahdi, Shivani Pandey

Naunyn-Schmiedeberg's Archives of Pharmacology · 2024-03 · 397 (3) · 1647-1658

DOI: 10.1007/s00210-023-02703-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 14.09.2023. Verfasst von Mrinal Gupta und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, King George's Medical University, Lucknow, Uttar Pradesh, India. Hauptthemen laut MEDLINE: Berberine, Diabetes Mellitus, Type 2, Diabetes Mellitus, Experimental, Hyperglycemia. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Berberine (BBR), a bioactive compound isolated from Coptidis Rhizoma, possesses diverse pharmacological activities including anti-bacterial, anti-inflammatory, antitumor, hypolipidemic, and anti-diabetic. However, its role as an anti-diabetic agent in animal models of dexamethasone (Dex)-induced diabetes remains unknown. Studies have shown that natural compounds including aloe, caper, cinnamon, cocoa, green and black tea, and turmeric can be used for treating Type 2 diabetes mellitus (DM). Compared to conventional drugs, natural compounds have less side effects and are easily available. Herein, we studied the anti-diabetic effects of BBR in a mice model of Dex-induced diabetes. HepG2 cell line was used for glucose release and glycogen synthesis studies. Cell proliferation was measured by methylthiotetrazole (MTT) assay. For animal studies, mice were treated with Dex (2 mg/kg, i.m.) for 30 days and effect of BBR at the doses 100, 200, and 500 mg/kg (p.o.) was analyzed. Glucose, insulin, and pyruvate tests were performed for evaluating the development of the diabetic model. Echo MRI was performed to assess the fat mass. Further, to elucidate the mechanism of action of BBR, mRNA expression of genes regulating gluconeogenesis, glucose uptake, and glycolysis was analyzed. In vitro BBR had no impact on cell viability up to a concentration of 50 μM. Moreover, BBR suppressed the hepatic glucose release and improved glucose tolerance in HepG2 cells. In vivo, BBR improved glucose homeostasis in diabetic mice as evidenced by enhanced glucose clearance, increased glycolysis, elevated glucose uptake, and decreased gluconeogenesis. Further, Dex treatment increased the total fat mass in mice, which was ameliorated by BBR treatment. BBR improves glucose tolerance by increasing glucose clearance, inhibiting hepatic glucose release, and decreasing obesity. Thus, BBR may become a potential therapeutic agent for treating glucocorticoid-induced diabetes and obesity in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BerberineDiabetes Mellitus, Type 2Diabetes Mellitus, ExperimentalHyperglycemiaMiceAnimalsGlucocorticoidsGlucoseAnti-Inflammatory AgentsObesity

Stichwörter der Autor:innen

BerberineGlucocorticoidGlucoseHepG2 cellsHyperglycemiaInsulin resistance

Substanzen

BerberineGlucocorticoidsGlucoseAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Biochemistry, King George's Medical University, Lucknow, Uttar Pradesh, India.
  • Department of Biosciences, Integral University, Lucknow, Uttar Pradesh, India.
  • Department of Biochemistry, King George's Medical University, Lucknow, Uttar Pradesh, India. drshivani111263@gmail.com.

Förderung

  • Indian Council of Medical Research

Zitieren

APA

Gupta, M., Rumman, M., Singh, B., Mahdi, A. A., & Pandey, S. (2024). Berberine ameliorates glucocorticoid-induced hyperglycemia: an in vitro and in vivo study. Naunyn-Schmiedeberg's Archives of Pharmacology, 397(3), 1647-1658. https://doi.org/10.1007/s00210-023-02703-2

Vancouver

Gupta M, Rumman M, Singh B, Mahdi AA, Pandey S. Berberine ameliorates glucocorticoid-induced hyperglycemia: an in vitro and in vivo study. Naunyn-Schmiedeberg's Archives of Pharmacology. 2024;397(3):1647-1658. doi:10.1007/s00210-023-02703-2

BibTeX
@article{Gupta2024,
  author = {Gupta, Mrinal and Rumman, Mohammad and Singh, Babita and Mahdi, Abbas Ali and Pandey, Shivani},
  title = {Berberine ameliorates glucocorticoid-induced hyperglycemia: an in vitro and in vivo study},
  journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
  year = {2024},
  volume = {397},
  number = {3},
  pages = {1647--1658},
  doi = {10.1007/s00210-023-02703-2}
}
Kostenlos starten →